Headlines

An overview of the biosimilars space

Biosimilar developer Formycon puts the spotlight on the opportunities and challenges for the sector.

Samsung Biologics and European pharma company enter major manufacturing deal

The global CDMO has entered into several high-value manufacturing deals this year.

FDA approves first-ever gene therapy to be directly administered to the brain

PTC Therapeutics has received FDA approval for a gene therapy to treat AADC deficiency, a rare genetic disorder that impairs the normal function of neurons.

Serious adverse event causes problems for Neurogene’s Rett gene therapy

A serious adverse event in the New York biotech’s phase 1/2 trial of its Rett syndrome gene therapy puts a question mark over the program.

Alentis raises $181 million to advance ADCs to the clinic

The Series D financing will support the clinical development of two ADCs.

SEKISUI Diagnostics completes £15.7M expansion to boost biopharma manufacturing capacity

New cGMP fermentation facility in the UK set to meet growing demand for drug substance production, supporting biopharma manufacturing at scale.

Promising early Parkinson’s immunotherapy results for AC Immune

The interim phase 2 trial results show a good immune response in participants and the therapy is well tolerated to date.

FDA removes clinical hold on Novavax’s COVID-19-influenza combo vaccine

The FDA had put a clinical hold on Novavax’s COVID-19-influenza combo vaccine after an adverse event in a patient.

Global Industry News

Trends

Spotlight

Helen Harrington’s journey: Patience, passion, and problem-solving

Innovative COA tools to reduce steroid toxicity in autoimmune care

AbbVie’s schizophrenia candidate fails in two phase 2 trials

Sarepta discontinues development of Duchenne ASO treatment vesleteplirsen

Aditum Bio and Leads Biolabs join forces in new company to fight autoimmune diseases

Webinars

On-demand webinars

Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROS Mixed-Mode Chromatography Media Thermo Fisher Scientific - Biosciences

Featured Suppliers

All

Headlines

An overview of the biosimilars space

Samsung Biologics and European pharma company enter major manufacturing deal

FDA approves first-ever gene therapy to be directly administered to the brain

Serious adverse event causes problems for Neurogene’s Rett gene therapy

Alentis raises $181 million to advance ADCs to the clinic

SEKISUI Diagnostics completes £15.7M expansion to boost biopharma manufacturing capacity

Promising early Parkinson’s immunotherapy results for AC Immune

FDA removes clinical hold on Novavax’s COVID-19-influenza combo vaccine

Global Industry News

Private equity firms GHO and Ampersand acquire Avid Bioservices for $1.1 billion

Insights from Tjoapack’s CEO: 35 years of pharma packaging:

Senhwa Biosciences starts trial of silmitasertib in children with difficult to treat cancers

Trends

Helen Harrington’s journey: Patience, passion, and problem-solving

Tran Pham: Breaking barriers and building biopharma solutions

Innovative COA tools to reduce steroid toxicity in autoimmune care

EMA accepts Alvotech and Advanz Pharma’s Marketing Authorization Application for biosimilar of J&J’s Simponi

Synaffix and BigHat Biosciences collaborate to develop AI-designed ADC

Top 10 rare disease pharma sees 10.4% rise in therapy start

Spotlight

Follow us

Most popular News

Webinars

Featured Suppliers

BioPharma-Reporter

Resources